NUE
44
4
UNP
36
3
PNC
59
2
COF
50
3
AAL
15
3
C
71
3
MAC
47
3
HIG
56
-2
FITB
53
3
EFX
41
-2
GOOG
65
2
PWR
62
-8
SEE
42
-2
JNJ
51
10
MSI
32
-11
RCL
79
3
WMT
52
2
MDT
57
-2
JCI
50
-10
CI
50
4
NUE
44
4
UNP
36
3
PNC
59
2
COF
50
3
AAL
15
3
C
71
3
MAC
47
3
HIG
56
-2
FITB
53
3
EFX
41
-2
GOOG
65
2
PWR
62
-8
SEE
42
-2
JNJ
51
10
MSI
32
-11
RCL
79
3
WMT
52
2
MDT
57
-2
JCI
50
-10
CI
50
4
Financhill
Back

CytomX Therapeutics 10K Form

Sell
38

CTMX
CytomX Therapeutics

Last Price:
$2.33
Seasonality Move:
-1.04%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

10K form not available

Receive CTMX News And Ratings

See the #1 stock for the next 7 days that we like better than CTMX

CTMX Financial Statistics

Sales & Book Value

Annual Sales: $138.1M
Cash Flow: $-21.2M
Price / Cash Flow: 0
Annual Sales: $0.31
Price / Book: 13.27

Profitability

EPS (TTM): 0.49000
Net Income (TTM): $41.6M
Gross Margin: $890K
Return on Equity: 0%
Return on Assets: 29.64%

CytomX Therapeutics Earnings Forecast

Key CytomX Therapeutics Financial Ratios

  • The Gross Profit Margin over the past 1 years for CTMX is 100.23%.
  • The Selling, General & Administrative Expenses for CTMX have been equal to 21.52% of Gross Profit Margin.
  • The Research & Development expenses have been 60.38% of Revenue.
  • The Net Earning history of CTMX is 23.08% of Total Revenues.
  • Per Share Earnings over the last 12 years have been positive in 6 years.

CytomX Therapeutics Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Industry: Biotechnology
Sector: Health Care
Current Symbol: CTMX
CUSIP: 23284F
Website: cytomx.com

Debt

Debt-to-Equity Ratio: 0
Current Ratio: 1.73
Quick Ratio: 1.63

Price-to-Earnings

Trailing P/E Ratio: 5.55
Forward P/E Ratio: 0

CTMX Technical Analysis vs Fundamental Analysis

Sell
38
CytomX Therapeutics (CTMX) is a Sell

Is CytomX Therapeutics a Buy or a Sell?